{
    "2021-07-18": [
        [
            {
                "time": "",
                "original_text": "瑞科生物冲刺港交所：单季亏损2.5亿 君联与红杉是股东 亏损",
                "features": {
                    "keywords": [
                        "瑞科生物",
                        "港交所",
                        "单季亏损",
                        "君联",
                        "红杉",
                        "股东"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "瑞科生物拟在港上市：斥巨资购买新冠疫苗专利，亏损规模持续扩大 亏损",
                "features": {
                    "keywords": [
                        "瑞科生物",
                        "港上市",
                        "新冠疫苗",
                        "专利",
                        "亏损规模",
                        "持续扩大"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：中报预告落地 个股表现持续分化",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "中报预告",
                        "个股表现",
                        "持续分化"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}